StonvexLoading…
StonvexStonvexStonvexCore line items from BRTX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $23.17K | $359.70K | $340.10K | $328.30K |
Operating Income | $-3.39M | $-15.65M | $-11.82M | $-8.11M |
Net Income | $-2.15M | $-14.24M | $-11.03M | $-2.66M |
EPS (Diluted) | $-0.12 | $-1.58 | $-1.26 | $-0.94 |
Total Assets | $4.64M | $4.08M | $5.64M | $8.52M |
Total Liabilities | Not available | Not available | Not available | $3.67M |
Cash & Equivalents | $3.11M | $1.51M | $602.44K | $1.56M |
Free Cash Flow OCF − CapEx | Not available | $-10.91M | $-8.41M | $-5.51M |
Shares Outstanding | 25.48M | 8.88M | 7.98M | 7.98M |